Who Holds Arcus Biosciences, Inc. (RCUS)? 230 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 230 holders, $3.7 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 31,424,760 | $969 million | +0% | 13F |
| BlackRock, Inc. | 16,416,249 | $506 million | +8% | 13F |
| STATE STREET CORP | 6,029,484 | $186 million | +11% | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 5,895,448 | $182 million | -3% | 13F |
| MONTANOVA CAPITAL, LLC | 4,776,423 | $147 million | -5% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,475,528 | $138 million | +5% | 13F |
| FMR LLC | 4,049,757 | $125 million | +248% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,888,346 | $120 million | +1% | 13F |
| CITADEL ADVISORS LLC | 3,135,057 | $97 million | +136% | 13F |
| Woodline Partners LP | 3,007,798 | $93 million | -20% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 2,448,749 | $76 million | +9% | 13F |
| Siren, L.L.C. | 2,420,430 | $75 million | -20% | 13F |
| Fisher Asset Management, LLC | 2,139,396 | $66 million | -2% | 13F |
| MARSHALL WACE, LLP | 1,945,088 | $60 million | -48% | 13F |
| SAMLYN CAPITAL, LLC | 1,547,182 | $48 million | -19% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 1,434,320 | $44 million | +1% | 13F |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,419,533 | $44 million | -14% | 13F |
| GOLDMAN SACHS GROUP INC | 1,387,566 | $43 million | +39% | 13F |
| Soleus Capital Management, L.P. | 1,168,738 | $36 million | +159% | 13F |
| Sofinnova Investments, Inc. | 945,690 | $29 million | +2% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 941,756 | $29 million | +4% | 13F |
| NORTHERN TRUST CORP | 932,523 | $29 million | +11% | 13F |
| Parkman Healthcare Partners LLC | 919,266 | $28 million | -24% | 13F |
| Invesco Ltd. | 845,233 | $26 million | +3% | 13F |
| BAKER BROS. ADVISORS LP | 844,816 | $26 million | +103% | 13F |
| BANK OF AMERICA CORP /DE/ | 835,504 | $26 million | +29% | 13F |
| MORGAN STANLEY | 795,912 | $25 million | -29% | 13F |
| Candriam S.C.A. | 661,981 | $20 million | -16% | 13F |
| Aberdeen Group plc | 650,712 | $20 million | -15% | 13F |
| Logos Global Management LP | 650,000 | $20 million | -46% | 13F |
| TWO SIGMA INVESTMENTS, LP | 635,404 | $20 million | +103% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 616,088 | $19 million | +6% | 13F |
| Bank of New York Mellon Corp | 543,009 | $17 million | +6% | 13F |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 512,084 | $16 million | +19% | 13F |
| Ikarian Capital, LLC | 504,559 | $16 million | New | 13F |
| Decheng Capital LLC | 464,779 | $14 million | -3% | 13F |
| DAFNA Capital Management LLC | 441,829 | $14 million | 0% | 13F |
| JPMORGAN CHASE & CO | 418,243 | $13 million | +418% | 13F |
| PRINCIPAL FINANCIAL GROUP INC | 423,366 | $13 million | +2% | 13F |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 379,100 | $12 million | +0% | 13F |
| UBS Group AG | 369,056 | $11 million | +28% | 13F |
| Patient Square Capital LP | 355,800 | $11 million | +82% | 13F |
| PDT Partners, LLC | 323,567 | $10 million | -17% | 13F |
| Public Sector Pension Investment Board | 298,156 | $9 million | -2% | 13F |
| FIRST TRUST ADVISORS LP | 271,434 | $8 million | +1972% | 13F |
| Nuveen, LLC | 234,052 | $7 million | +6% | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 225,008 | $7 million | -20% | 13F |
| DIADEMA PARTNERS LP | 223,810 | $7 million | -6% | 13F |
| RHUMBLINE ADVISERS | 219,181 | $7 million | -9% | 13F |
| Ensign Peak Advisors, Inc | 215,613 | $7 million | -15% | 13F |
| Legal & General Group Plc | 191,560 | $6 million | +2% | 13F |
| Rock Springs Capital Management LP | 180,000 | $6 million | +0% | 13F |
| Swiss National Bank | 176,096 | $5 million | +3% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 154,398 | $5 million | -2% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 154,264 | $5 million | New | 13F |
| AMERIPRISE FINANCIAL INC | 153,813 | $5 million | -4% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 153,109 | $5 million | -60% | 13F |
| PFM Health Sciences, LP | 152,129 | $5 million | New | 13F |
| Hudson Bay Capital Management LP | 140,000 | $4 million | -61% | 13F |
| Man Group plc | 137,763 | $4 million | +70% | 13F |
| PLATINUM INVESTMENT MANAGEMENT LTD | 134,217 | $4 million | +0% | 13F |
| MILLENNIUM MANAGEMENT LLC | 133,110 | $4 million | New | 13F |
| Schonfeld Strategic Advisors LLC | 122,574 | $4 million | -37% | 13F |
| CITIGROUP INC | 112,238 | $3 million | +325% | 13F |
| SECTORAL ASSET MANAGEMENT INC | 110,870 | $3 million | +146% | 13F |
| PRUDENTIAL FINANCIAL INC | 110,603 | $3 million | +26% | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 97,410 | $3 million | -8% | 13F |
| D. E. Shaw & Co., Inc. | 96,417 | $3 million | -63% | 13F |
| DEUTSCHE BANK AG\ | 94,710 | $3 million | +28% | 13F |
| ALLIANCEBERNSTEIN L.P. | 126,975 | $3 million | +2% | 13F |
| Parallel Advisors, LLC | 86,557 | $3 million | +0% | 13F |
| Odyssean, LLC | 85,497 | $3 million | New | 13F |
| Tidal Investments LLC | 85,126 | $3 million | -1% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 83,861 | $3 million | -3% | 13F |
| Tema ETFs LLC | 83,140 | $3 million | +11% | 13F |
| WELLS FARGO & COMPANY/MN | 82,913 | $3 million | +132% | 13F |
| STATE OF WISCONSIN INVESTMENT BOARD | 82,399 | $3 million | +39% | 13F |
| Jump Financial, LLC | 82,036 | $3 million | -40% | 13F |
| Russell Investments Group, Ltd. | 81,549 | $3 million | +1% | 13F |
| Knott David M Jr | 81,241 | $3 million | +0% | 13F |
| Rafferty Asset Management, LLC | 71,725 | $2 million | -38% | 13F |
| VANGUARD ASSET MANAGEMENT, Ltd | 63,528 | $2 million | +14% | 13F |
| Caption Management, LLC | 62,000 | $2 million | +287% | 13F |
| FRED ALGER MANAGEMENT, LLC | 60,494 | $2 million | New | 13F |
| BIT Capital GmbH | 60,000 | $2 million | New | 13F |
| Corient Private Wealth LP | 59,127 | $2 million | +145% | 13F |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 59,021 | $2 million | +16% | 13F |
| Quantinno Capital Management LP | 57,255 | $2 million | +231% | 13F |
| Persistent Asset Partners Ltd | 57,048 | $2 million | -5% | 13F |
| RAYMOND JAMES FINANCIAL INC | 53,680 | $2 million | +42% | 13F |
| Susquehanna Portfolio Strategies, LLC | 53,668 | $2 million | -78% | 13F |
| WINTON GROUP Ltd | 52,398 | $2 million | +60% | 13F |
| MetLife Investment Management, LLC | 52,110 | $2 million | +16% | 13F |
| Illinois Municipal Retirement Fund | 51,214 | $2 million | +41% | 13F |
| SummitTX Capital, L.P. | 50,463 | $2 million | +47% | 13F |
| Burkehill Global Management, LP | 50,000 | $2 million | +0% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 49,526 | $2 million | +4% | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 45,826 | $1 million | +9% | 13F |
| Jupiter Topco LLC | 42,338 | $1 million | New | 13F |
| Vanguard Global Advisers, LLC | 40,500 | $1 million | -4% | 13F |
Questions and answers
- How many institutions hold Arcus Biosciences, Inc.?
- 230 managers reported Arcus Biosciences, Inc. on Form 13F for the quarter ended 30 June 2026, against 211 the quarter before.
- Who is the largest institutional holder of Arcus Biosciences, Inc.?
- GILEAD SCIENCES, INC., with 31,424,760 shares worth $969 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Arcus Biosciences, Inc. in Q2 2026?
- 46 managers reported a new position and 27 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Arcus Biosciences, Inc., Q2 2026", https://app.tamarly.ai/holders/arcus-biosciences, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.